Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL614426 | 0.79 | LMNA (0.44) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL23036042 | 0.79 | TSHR (0.41) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL9392455 | 0.77 | LMNA (0.46) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| Mannitol SCHEMBL3725317 | 0.76 | LMNA (0.55) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL1173141 | 0.75 | USP2 (0.37) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL14759689 | 0.74 | USP2 (0.39) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL5807432 | 0.73 | USP2 (0.41) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL11206594 | 0.72 | LMNA (0.50) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL8864832 | 0.72 | TDP1 (0.40) | USP2SLCO1B1LMNAL3MBTL1PDE4A | |
| SCHEMBL2678840 | 0.71 | USP2 (0.53) | USP2SLCO1B1LMNAL3MBTL1PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0607252-A4 | METHOD OF TREATING HIV INFECTION. | THOENE JESS G (US) | 1996-03-13 | — | — | EP | claimed |
| EP-0607252-A1 | METHOD OF TREATING HIV INFECTION | THOENE, Jess G. (US) | 1994-07-27 | — | — | EP | claimed |
| WO-1993006832-A1 | METHOD OF TREATING HIV INFECTION | THOENE JESS G (US) | 1993-04-15 | — | — | WO | claimed |
| US-12569456-B2 | Methods for the treatment of cysteamine sensitive disorders | THIOGENESIS THERAPEUTICS, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| EP-4659736-A1 | HAIR-SHAPE-IMPARTING METHOD | Kao Corporation (JP) | 2025-12-10 | — | — | EP | disclosed |
| EP-4534527-A2 | METHODS FOR THE TREATMENT OF CYSTEAMINE SENSITIVE DISORDERS | Thiogenesis Therapeutics, Inc. (US) | 2025-04-09 | — | — | EP | disclosed |
| EP-3684418-B1 | COMPOUNDS FOR THE TREATMENT OF CYSTEAMINE SENSITIVE DISORDERS | THIOGENESIS THERAPEUTICS INC (US) | 2025-02-12 | — | — | EP | disclosed |
| WO-2024162257-A1 | HAIR-SHAPE-IMPARTING METHOD | 花王株式会社 | 2024-08-08 | — | — | WO | disclosed |
| US-11786491-B2 | Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders | THIOGENESIS THERAPEUTICS, INC. (US) | 2023-10-17 | — | — | US | disclosed |
| US-20230218571-A1 | CYSTEAMINE PRECURSOR COMPOUNDS FOR THE TREATMENT OF BETACORONAVIRUS INFECTIONS | THIOGENESIS THERAPEUTICS, INC. | 2023-07-13 | — | — | US | disclosed |
| US-20230190683-A1 | METHODS FOR THE TREATMENT OF CYSTEAMINE SENSITIVE DISORDERS | THIOGENESIS THERAPEUTICS, INC. | 2023-06-22 | — | — | US | disclosed |
| US-6156077-A | Hair cosmetic composition comprising an oxyalkylenized xanthan gum | KAO CORPORATION (JP) | 2000-12-05 | — | — | US | disclosed |
| US-5958084-A | CONSISTS OF AN OXIDATION DYE PRECURSOR, A COUPLER AND AN OXYALKYLENIZED XANTHANE GUM, AND A SALT OF INORGANIC ACID OR ORGANIC ACID | KAO CORPORATION (JP) | 1999-09-28 | — | — | US | disclosed |
| EP-0607252-B1 | COMPOSITIONS FOR THE TREATMENT OF HIV INFECTION | THOENE JESS G (US) | 1998-11-25 | — | — | EP | disclosed |
| EP-0784970-A2 | Hair cosmetic composition | Kao Corporation (JP) | 1997-07-23 | — | — | EP | disclosed |
| US-5609860-A | Curly hair-straightening composition | KAO CORPORATION (JP) | 1997-03-11 | — | — | US | disclosed |
| EP-0607252-A4 | METHOD OF TREATING HIV INFECTION. | THOENE JESS G (US) | 1996-03-13 | — | — | EP | disclosed |
| EP-0658338-A1 | Curly hair-straightening composition comprising keratin reducing substances and alcohols | KAO CORPORATION (JP) | 1995-06-21 | — | — | EP | disclosed |
| EP-0607252-A1 | METHOD OF TREATING HIV INFECTION | THOENE, Jess G. (US) | 1994-07-27 | — | — | EP | disclosed |
| WO-1993006832-A1 | METHOD OF TREATING HIV INFECTION | THOENE JESS G (US) | 1993-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12569456-B2 | Methods for the treatment of cysteamine sensitive disorders | SLC7A11, CTH, SLC19A1 | USP2 2853/4885SLCO1B1 969/4885LMNA 2114/4885 |
| US-20230218571-A1 | CYSTEAMINE PRECURSOR COMPOUNDS FOR THE TREATMENT OF BETACORONAVIRUS INFECTIONS | CBS, CTH, BHMT | USP2 358/4885SLCO1B1 931/4885LMNA 4283/4885 |
| US-20230190683-A1 | METHODS FOR THE TREATMENT OF CYSTEAMINE SENSITIVE DISORDERS | CTH, CBS, SLC19A1 | USP2 1315/4885SLCO1B1 128/4885LMNA 3089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.